Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Jan 13, 2022 10:34am
150 Views
Post# 34312503

Key Paragraphs from article in The Globe...

Key Paragraphs from article in The Globe...The support of SQI's partner (UHN) is significant.  UHN was awarded $24M from the Government of Canada.  This will turbo charge things for SQI as well.
  
See a few paragraphs from the Globe here below.  

In total, seven projects will receive $144-million over the next six years under the government’s New Frontiers in Research Fund, following a two-year selection process that initially drew more than 300 proposals....

Ted Hewitt, president of the Social Sciences and Humanities Research Council (SSHRC), which administered the competition on behalf of a cross-agency co-ordinating committee, said the goal of the funding call was to promote ideas that would be “fundamentally transformative” and to encourage researchers to work across academic and funding boundaries in ways they hadn’t before....
 
The successful projects were unveiled on Wednesday by federal Minister of Innovation, Science and Industry Franois-Philippe Champagne during a virtual press event....

At the other end of the spectrum is a project led by the University Health Network at the University of Toronto to improve the preservation of organs for successful transplants. The project will build on previous successes, including the development of machines for maintaining lungs at body temperature while they are assessed for transplants, and will seek to extend the technology to systems for the liver, kidney, pancreas and heart.

Dominique Brub, vice-president of research at SSHRC, said the project was an example of the kind of high-risk, high-reward science that would be a challenge to support through the usual federal funding streams and timelines because of its size and the required combination of expertise.

“It was very obvious from the evaluation that there was no other way we could have funded that in Canada,” she said. “And if we can’t fund that project, it’s going to go somewhere else.”


<< Previous
Bullboard Posts
Next >>